Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

被引：0
|
作者：
Roy, Susmit Prosun [1 ,2 ]
Al Zhahrani, Nayef [2 ,3 ]
Barat, Shoma [4 ,5 ]
Morris, David L. [2 ,5 ,6 ,7 ]
机构：
[1] Univ Newcastle, John Hunter Hosp, Gen Surg, Newcastle, NSW, Australia
[2] St George Hosp, Liver & Peritonect Unit, Kogarah, NSW, Australia
[3] Al Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia
[4] Southeast Sydney Local Hlth Dist, Sydney, NSW, Australia
[5] Univ New South Wales, Sydney, NSW, Australia
[6] UNSW, St George & Sutherland Clin Sch, Sydney, NSW 2052, Australia
[7] St George & Sutherland Clin Sch, Kogarah, NSW 2217, Australia
来源：
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2022年 / 94卷
关键词：
Peritonectomy; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; High grade appendiceal cancer; Oxaliplatin; Mitomycin; C; Case series; LONG-TERM SURVIVAL; PSEUDOMYXOMA; METASTASES; EXPERIENCE; MANAGEMENT;
D O I：
10.1016/j.ijscr.2022.107027
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Background: Pseudomyxoma Peritonei (PMP) is a mucin producing cancer with appendix as primary site. Cytoreductive Surgery (CRS) combined with hyper-thermic intraperitoneal chemotherapy (HIPEC) is an established form of therapy known to prolong survival in patients with PMP and peritoneal carcinomatosis.Methods/patientsIn our case series, we present five cases of PMP with synchronous liver and peritoneal metastasis treated with CRS and HIPEC.It is a very rare condition which needs more research to be able to comment on overall survival.Results: However, in our study, we found lower age, female gender and complete cytoreduction in surgery to be favourable predictors for improved morbidity.Conclusion: In our experience, CRS/HIPEC seem to be feasible for patients with PMP with synchronous liver and peritoneal metastasis.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis
    Pallas, Nicolaos
    Karamveri, Christina
    Kyziridis, Dimitrios
    Hristakis, Christos
    Kyriakopoulos, Vasileios
    Kalakonas, Apostolos
    Vaikos, Dimitrios
    Tentes, Antonios-Apostolos K.
    [J]. JOURNAL OF BUON, 2017, 22 (06): : 1547 - 1553
  • [2] Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Cummins, Kathleen A.
    Russell, Gregory B.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Stewart, John H.
    Levine, Edward A.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (01) : 3 - 9
  • [3] Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Mangieri, Christopher W.
    Moaven, Omeed
    Valenzuela, Cristian D.
    Erali, Richard A.
    Votanopoulos, Konstantinos, I
    Shen, Perry
    Levine, Edward A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (04) : 2641 - 2648
  • [4] Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis
    Rihuete Caro, Cristina
    Manzanedo, Israel
    Pereira, Fernando
    Carrion-Alvarez, Lucia
    Serrano, Angel
    Perez-Viejo, Estibalitz
    [J]. EJSO, 2018, 44 (11): : 1805 - 1810
  • [5] Predictors of Progression in High-Grade Appendiceal or Colorectal Peritoneal Carcinomatosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Baumgartner, Joel M.
    Tobin, Laura
    Heavey, Sean F.
    Kelly, Kaitlyn J.
    Roeland, Eric J.
    Lowy, Andrew M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1716 - 1721
  • [6] Predictors of Progression in High-Grade Appendiceal or Colorectal Peritoneal Carcinomatosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Joel M. Baumgartner
    Laura Tobin
    Sean F. Heavey
    Kaitlyn J. Kelly
    Eric J. Roeland
    Andrew M. Lowy
    [J]. Annals of Surgical Oncology, 2015, 22 : 1716 - 1721
  • [7] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis
    Nesher, Eviatar
    Greenberg, Ron
    Avital, Shmuel
    Skornick, Yehuda
    Schneebaunn, Schlomo
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 787 - 790
  • [8] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Khan, Hadi M.
    Hanif, Hamza
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
  • [9] Quality of Life in Peritoneal Carcinomatosis: A Prospective Study in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Albertsmeier, Markus
    Hauer, Alexandra
    Niess, Hanno
    Werner, Jens
    Graeb, Christian
    Angele, Martin K.
    [J]. DIGESTIVE SURGERY, 2014, 31 (4-5) : 334 - 340
  • [10] Predictive Factors of Peritoneal Carcinomatosis from Appendiceal Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Jimenez, W. A.
    Sardi, A.
    Nieroda, C.
    Sittig, M.
    Nunez, M. F.
    MacDonald, R.
    Milovanov, V.
    Aydin, N.
    Gushchin, V.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S133 - S134
12345